Matsunaga Shinji

マツナガシンジ | Matsunaga Shinji

Affiliation and department：
Job title： Lecturer

Research field (1)： Pharmacology

Research keywords (3)：腫瘍血管 , 腫瘍 , 抗癌剤

Research theme for competitive and other funds (1)：

2017 - 2019 抗癌剤増感作用をもたらす腫瘍内血管再構築機構の解明

Papers (17)：

Shunji Nishide, Shinji Matsunaga, Masayuki Shiota, Takehiro Yamaguchi, Shojiro Kitajima, Yoichi Maekawa, Norihiko Takeda, Michio Tomura, Junji Uchida, Katsuyuki Miura, et al. Controlling the Phenotype of Tumor-Infiltrating Macrophages via the PHD-HIF Axis Inhibits Tumor Growth in a Mouse Model. iScience. 2019. 21. 205-205
Shunji Nishide, Shinji Matsunaga, Masayuki Shiota, Takehiro Yamaguchi, Shojiro Kitajima, Yoichi Maekawa, Norihiko Takeda, Michio Tomura, Junji Uchida, Katsuyuki Miura, et al. Controlling the Phenotype of Tumor-Infiltrating Macrophages via the PHD-HIF Axis Inhibits Tumor Growth in a Mouse Model. iScience. 2019. 19. 940-954
Yamaguchi Takehiro, Watanabe Ayano, Tanaka Masako, Shiota Masayuki, Osada-Oka Mayuko, Sano Soichi, Yoshiyama Minoru, Miura Katsuyuki, Kitajima Shojiro, Matsunaga Shinji, et al. ジペプチジルペプチダーゼ-4(DPP-4)阻害剤リナグリプチンは、DPP-4とは無関係に心筋梗塞後の心機能障害を軽減する(A dipeptidyl peptidase-4(DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4). (公社)日本薬理学会 Journal of Pharmacological Sciences. 2019. 139. 2. 112-119
Yamaguchi Takehiro, Watanabe Ayano, Tanaka Masako, Shiota Masayuki, Osada-Oka Mayuko, Sano Soichi, Yoshiyama Minoru, Miura Katsuyuki, Kitajima Shojiro, Matsunaga Shinji, et al. A dipeptidyl peptidase-4(DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4(和訳中). (公社)日本薬理学会 Journal of Pharmacological Sciences. 2019. 139. 2. 112-119
Yamaguchi T, Watanabe A, Tanaka M, Shiota M, Osada-Oka M, Sano S, Yoshiyama M, Miura K, Kitajima S, Matsunaga S, et al. A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4. Journal of pharmacological sciences. 2019. 139. 2. 112-119

ｍore...

Patents (2)：

腫瘍関連マクロファージ賦活化剤
抗癌剤の抗腫瘍効果の増強剤、癌治療剤、及び癌治療用医薬組成物

Education (6)：

2007 - 2011 Tottori University Graduate School, Division of Medical Sciences
2007 - 2011 Tottori University Graduate School, Division of Medical Sciences
2004 - 2006 Gifu Pharmaceutical University Graduate School, Division of Pharmaceutical Sciences
2004 - 2006 Gifu Pharmaceutical University Graduate School, Division of Pharmaceutical Sciences
2000 - 2004 Gifu Pharmaceutical University Faculty of Pharmaceutical Science

Show all

Professional career (2)：

博士(医学) (鳥取大学)
修士(薬学) (岐阜薬科大学)

Work history (10)：

2016/07/01 - 現在 Osaka City University Graduate School of Medicine Basic Medicine Course Lecturer
2016/07 - 2017/09 大阪市立大学医学研究科基礎医科学専攻分子病態薬理学助教
2013/05 - 2016/06 鳥取大学医学部病態解析医学講座分子薬理学分野助教
2013/05 - 2016/06 鳥取大学医学部病態解析医学講座分子薬理学分野助教
2011/07 - 2013/04 University of Texas Southwestern Medical Center Department of Radiation Oncology Post Doctoral Fellow

Show all

Association Membership(s) (4)：

日本薬学会 , 日本癌学会 , 日本臨床薬理学会 , 日本薬理学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page